Royalty Pharma plc Class A Ordinary Shares RPRX
$58.60
+0.07%
at last close
Financials (TTM)
- Revenue
- $2.54 billion
- Net Income
- $1.35 billion
- Net Margin
- 53.23%
- Return on Equity
- 13.79%
- Debt-to-Equity
- 0.92
- P/E Ratio
- 31.17
- Price / Book
- 2.69
- Price / Sales
- 10.40
Over the trailing twelve months, Royalty Pharma plc Class A Ordinary Shares generated revenue of $2.54 billion and net income of $1.35 billion, a net margin of 53.23%.
At the last closing price of $58.60, RPRX trades at 31.17 times trailing earnings and 10.40 times sales, with a market capitalization of $26.37 billion.
Key Stats
- Last Close
- $58.60
- Market Cap
- $26.37 billion
- 52-Week Range
- $34.08 – $60.44
- Average Volume
- 2.85 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.